115 related articles for article (PubMed ID: 15345309)
1. The induction of eosinophil peroxidase release: improved methods of measurement and stimulation.
Adamko DJ; Wu Y; Gleich GJ; Lacy P; Moqbel R
J Immunol Methods; 2004 Aug; 291(1-2):101-8. PubMed ID: 15345309
[TBL] [Abstract][Full Text] [Related]
2. [The measurement of superoxide generation and eosinophil peroxidase (EPO) from eosinophils].
Okada C; Soda R; Takahashi K
Nihon Rinsho; 1993 Mar; 51(3):730-5. PubMed ID: 8388065
[TBL] [Abstract][Full Text] [Related]
3. Human eosinophils express a receptor for secretory component. Role in secretory IgA-dependent activation.
Lamkhioued B; Gounni AS; Gruart V; Pierce A; Capron A; Capron M
Eur J Immunol; 1995 Jan; 25(1):117-25. PubMed ID: 7843220
[TBL] [Abstract][Full Text] [Related]
4. Inhibitors of chymotrypsin-like proteases inhibit eosinophil peroxidase release from activated human eosinophils.
Matsunaga Y; Kido H; Kawaji K; Kamoshita K; Katunuma N; Ogura T
Arch Biochem Biophys; 1994 Jul; 312(1):67-74. PubMed ID: 8031148
[TBL] [Abstract][Full Text] [Related]
5. Eosinophilic granuloma of the bone in Hand-Schüller-Christian disease: extensive in vivo eosinophil degranulation and subsequent binding of released eosinophil peroxidase (EPO) to other inflammatory cells.
Zabucchi G; Soranzo MR; Menegazzi R; Cattin L; Vecchio M; Lanza F; Patriarca P
J Pathol; 1991 Mar; 163(3):225-31. PubMed ID: 1707451
[TBL] [Abstract][Full Text] [Related]
6. Extracellular release of rat eosinophil peroxidase (EPO) I. Role of anaphylactic immunoglobulins.
Khalife J; Capron M; Grzych JM; Bazin H; Capron A
J Immunol; 1985 Mar; 134(3):1968-74. PubMed ID: 3968436
[TBL] [Abstract][Full Text] [Related]
7. [Inhibitory effect of AS-35. a novel antiallergic drug, on chemical mediator release from human eosinophils].
Kawashima T; Nagaki S; Iwakaji A; Iwamoto I; Yoshida S; Tomioka H
Arerugi; 1994 Dec; 43(11):1326-30. PubMed ID: 7887808
[TBL] [Abstract][Full Text] [Related]
8. Allergen extracts directly mobilize and activate human eosinophils.
Svensson L; Rudin A; Wennerås C
Eur J Immunol; 2004 Jun; 34(6):1744-51. PubMed ID: 15162445
[TBL] [Abstract][Full Text] [Related]
9. Mutual influence between eosinophil peroxidase (EPO) and neutrophils: neutrophils reversibly inhibit EPO enzymatic activity and EPO increases neutrophil adhesiveness.
Zabucchi G; Menegazzi R; Cramer R; Nardon E; Patriarca P
Immunology; 1990 Apr; 69(4):580-7. PubMed ID: 2335377
[TBL] [Abstract][Full Text] [Related]
10. Augmentation of stimulated eosinophil degranulation by VLA-4 (CD49d)-mediated adhesion to fibronectin.
Neeley SP; Hamann KJ; Dowling TL; McAllister KT; White SR; Leff AR
Am J Respir Cell Mol Biol; 1994 Aug; 11(2):206-13. PubMed ID: 8049081
[TBL] [Abstract][Full Text] [Related]
11. Paradoxical blockade of beta adrenergically mediated inhibition of stimulated eosinophil secretion by salmeterol.
Muñoz NM; Rabe KF; Vita AJ; McAllister K; Mayer D; Weiss M; Leff AR
J Pharmacol Exp Ther; 1995 May; 273(2):850-4. PubMed ID: 7752089
[TBL] [Abstract][Full Text] [Related]
12. Human eosinophil peroxidase: purification and characterization.
Carlson MG; Peterson CG; Venge P
J Immunol; 1985 Mar; 134(3):1875-9. PubMed ID: 3918110
[TBL] [Abstract][Full Text] [Related]
13. [Inhibition of eosinophil peroxidase release by chymotrypsin type protease inhibitors from activated human eosinophils].
Kawaji K; Matsunaga Y; Kido H; Ogura T
Arerugi; 1993 Oct; 42(10):1591-9. PubMed ID: 8250722
[TBL] [Abstract][Full Text] [Related]
14. Occult deposition of eosinophil peroxidase in a subset of human breast carcinomas.
Samoszuk MK; Nguyen V; Gluzman I; Pham JH
Am J Pathol; 1996 Mar; 148(3):701-6. PubMed ID: 8774125
[TBL] [Abstract][Full Text] [Related]
15. Eosinophil peroxidase is detectable with a monoclonal antibody in collagen bands of nodular sclerosis Hodgkin's disease.
Samoszuk M; Sholly S; Epstein AL
Lab Invest; 1987 Apr; 56(4):394-400. PubMed ID: 3550288
[TBL] [Abstract][Full Text] [Related]
16. Regulatory mechanism of eosinophil peroxidase release from guinea pig eosinophils.
Kirino Y; Mio M; Kamei C
Jpn J Pharmacol; 2000 Aug; 83(4):293-9. PubMed ID: 11001174
[TBL] [Abstract][Full Text] [Related]
17. Virus-induced eosinophil mediator release requires antigen-presenting and CD4+ T cells.
Davoine F; Cao M; Wu Y; Ajamian F; Ilarraza R; Kokaji AI; Moqbel R; Adamko DJ
J Allergy Clin Immunol; 2008 Jul; 122(1):69-77, 77.e1-2. PubMed ID: 18472150
[TBL] [Abstract][Full Text] [Related]
18. Uptake of human eosinophil peroxidase by human neutrophils.
Zabucchi G; Menegazzi R; Soranzo MR; Patriarca P
Am J Pathol; 1986 Sep; 124(3):510-8. PubMed ID: 3020987
[TBL] [Abstract][Full Text] [Related]
19. [Induction of granule release by intracellular application of Ca and GTP gamma S in human eosinophils].
Aizawa T; Kakuta Y; Tamura G; Shirato K
Nihon Rinsho; 1993 Mar; 51(3):620-5. PubMed ID: 8492434
[TBL] [Abstract][Full Text] [Related]
20. Adhesion-dependent interactions between eosinophils and cholinergic nerves.
Kingham PJ; McLean WG; Sawatzky DA; Walsh MT; Costello RW
Am J Physiol Lung Cell Mol Physiol; 2002 Jun; 282(6):L1229-38. PubMed ID: 12003778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]